FDA.reportPublic FDA data

neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz]

RxCUI
1429282
RxNorm name
neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz]
Display name
neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz]
Full name
neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BloxiverzNEOSTIGMINE METHYLSULFATEExela Pharma Sciences, LLCd2f55643-2b0d-4ef9-a9d8-b7138b3143722023-12-31Warnings, Adverse reactionsExact identifier
rxcui: 1429282

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
d2f55643-2b0d-4ef9-a9d8-b7138b314372neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz]SBD18These highlights do not include all the information needed to use BLOXIVERZ ® safely and effectively. See full prescribing information for BLOXIVERZ. BLOXIVERZ (Neostigmine Methylsulfate Injection), for intravenous use Initial U.S. Approval: 193920231231
d2f55643-2b0d-4ef9-a9d8-b7138b314372Bloxiverz 0.5 MG/ML Injectable SolutionPSN18These highlights do not include all the information needed to use BLOXIVERZ ® safely and effectively. See full prescribing information for BLOXIVERZ. BLOXIVERZ (Neostigmine Methylsulfate Injection), for intravenous use Initial U.S. Approval: 193920231231
d2f55643-2b0d-4ef9-a9d8-b7138b314372Bloxiverz 0.5 MG/ML Injectable SolutionSY18These highlights do not include all the information needed to use BLOXIVERZ ® safely and effectively. See full prescribing information for BLOXIVERZ. BLOXIVERZ (Neostigmine Methylsulfate Injection), for intravenous use Initial U.S. Approval: 193920231231